CVM GFI #261 - Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 14, 2021
July 13, 2021
f14b98b9-4e54-4fbf-8ced-f5788ccefc39
Related Documents
CVM GFI #265 Use of Data from Foreign Investigational Studies to Support Effectiveness of New Animal Drugs
Guidance DocumentOctober 6, 2021Center for Veterinary Medicine
CVM GFI #278 Human User Safety in New and Abbreviated New Animal Drug Applications
Guidance DocumentJune 21, 2024Center for Veterinary Medicine
CVM GFI #268 Adaptive and Other Innovative Designs for Effectiveness Studies of New Animal Drugs
Guidance DocumentOctober 6, 2021Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.